Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Gains from Investment Securities (2016 - 2025)

Collegium Pharmaceutical has reported Gains from Investment Securities over the past 11 years, most recently at -$19000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 99.35% year-over-year to -$19000.0; the TTM value through Dec 2025 reached -$3.3 million, up 70.17%, while the annual FY2025 figure was -$1.2 million, 247.12% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$19000.0 at Collegium Pharmaceutical, roughly flat from -$19000.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $3.2 million in Q2 2021 and troughed at -$8.1 million in Q4 2023.
  • A 5-year average of -$243152.7 and a median of -$7481.5 in 2024 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: soared 3255.56% in 2022 and later crashed 14414.29% in 2023.
  • Year by year, Gains from Investment Securities stood at -$1.1 million in 2021, then soared by 95.1% to -$56000.0 in 2022, then crashed by 14414.29% to -$8.1 million in 2023, then skyrocketed by 64.15% to -$2.9 million in 2024, then soared by 99.35% to -$19000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for COLL at -$19000.0 in Q4 2025, -$19000.0 in Q3 2025, and -$358000.0 in Q2 2025.